Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Follicular Lymphoma”
Phase 3 2
- OdronextamabREGENERON PHARMACEUTICALS, INC.Follicular Lymphoma (FL); Relapsed/Refractory Follicular Lymphoma
- SurovatamigASTRAZENECA PLCUntreated Follicular Lymphoma
Phase 2/3 1
- MK-1045Merck & Co., Inc.Follicular Lymphoma
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.